Sample/JJ
Size/NN
and/CC
Power/NN
Estimation/NN
in/IN
Case-Control/NN
Genetic/JJ
Association/NN
Studies/NNS
./.
====================
In/IN
planning/JJ
a/DT
genetic/JJ
association/NN
study/NN
,/,
it/PRP
is/VBZ
necessary/JJ
to/TO
determine/VB
the/DT
number/NN
of/IN
samples/NNS
to/TO
be/VB
collected/VBN
for/IN
the/DT
study/NN
in/IN
order/NN
to/TO
achieve/VB
sufficient/JJ
power/JJR
to/TO
detect/VB
the/DT
hypothesized/VBN
effect/NN
./.
====================
The/DT
case-control/JJ
design/NN
is/VBZ
increasingly/RB
used/VBN
for/IN
genetic/JJ
association/NN
studies/NNS
due/IN
to/TO
the/DT
simplicity/NN
of/IN
its/PRP$
design/NN
./.
====================
We/PRP
review/VBP
the/DT
methods/NNS
for/IN
the/DT
sample/NN
size/NN
and/CC
power/JJR
calculations/NNS
in/IN
case-control/JJ
genetic/JJ
association/NN
studies/NNS
between/IN
a/DT
marker/NN
locus/NN
and/CC
a/DT
disease/NN
phenotype/NN
./.
====================
Genetic/JJ
association/NN
studies/NNS
assess/VBP
correlations/NNS
between/IN
a/DT
disease/NN
phenotype/NN
and/CC
a/DT
marker/NN
genotype/NN
on/IN
a/DT
pop­/JJ
====================
ulation/NN
or/CC
family-based/VBN
scale/NN
./.
====================
In/IN
some/DT
respects/NNS
,/,
testing/VBG
for/IN
an/DT
association/NN
between/IN
a/DT
disease/NN
phenotype/NN
and/CC
a/DT
marker/NN
locus/NN
is/VBZ
not/RB
different/JJ
from/IN
testing/VBG
for/IN
statistical/JJ
as­/NN
sociation/NN
between/IN
any/DT
two/CD
variables/NNS
,/,
regardless/RB
of/IN
being/VBG
genetic/JJ
or/CC
not/RB
./.
====================
Thus/RB
,/,
many/JJ
statistical/JJ
methods/NNS
used/VBN
to/TO
analyze/VB
ordinary/JJ
statistical/JJ
association/NN
are/VBP
also/RB
used/VBN
for/IN
genetic/JJ
association/NN
./.
====================
However/RB
,/,
there/EX
are/VBP
important/JJ
differ­/JJ
ences/VBZ
between/IN
genetic/JJ
association/NN
and/CC
statistical/JJ
asso­/NN
ciation/NN
in/IN
the/DT
study/NN
design/NN
and/CC
analysis/NN
./.
====================
Genetic/JJ
association/NN
studies/NNS
have/VBP
been/VBN
mostly/RB
performed/VBN
in/IN
a/DT
case-control/JJ
study/NN
setting/VBG
that/DT
has/VBZ
been/VBN
well/RB
developed/VBN
for/IN
use/NN
in/IN
epidemiological/JJ
methods/NNS
(/(
Romero/NNP
et/FW
al./FW
,/,
2002/CD
)/)
./.
====================
The/DT
case-control/JJ
design/NN
is/VBZ
increasingly/RB
used/VBN
for/IN
genetic/JJ
association/NN
studies/NNS
due/IN
to/TO
its/PRP$
simplicity/NN
in/IN
design/NN
./.
====================
Significant/JJ
differences/NNS
in/IN
allele/NN
frequencies/NNS
or/CC
genotype/NN
frequencies/NNS
between/IN
cases/NNS
and/CC
controls/VBZ
are/VBP
taken/VBN
as/IN
evidence/NN
for/IN
involvement/NN
of/IN
an/DT
allele/NN
or/CC
genotype/NN
in/IN
disease/NN
susceptibility/NN
./.
====================
In/IN
planning/NN
a/DT
genetic/JJ
association/NN
study/NN
,/,
it/PRP
is/VBZ
necessary/JJ
to/TO
determine/VB
the/DT
====================
number/NN
of/IN
samples/NNS
to/TO
be/VB
collected/VBN
for/IN
the/DT
study/NN
in/IN
order/NN
to/TO
achieve/VB
sufficient/JJ
power/JJR
to/TO
detect/VB
the/DT
hypothesized/VBN
effect/NN
./.
====================
A/DT
genetic/JJ
association/NN
study/NN
that/IN
is/VBZ
conducted/VBN
without/IN
attention/NN
to/TO
sample/JJ
size/NN
or/CC
power/JJR
information/NN
takes/VBZ
the/DT
risks/NNS
of/IN
either/CC
failing/VBG
to/TO
detect/VB
important/JJ
meaningful/JJ
differences/NNS
(/(
i.e./FW
,/,
type/NN
II/CD
error/NN
)/)
or/CC
taking/VBG
an/DT
unnecessarily/RB
excessive/JJ
number/NN
of/IN
samples/NNS
for/IN
a/DT
study/NN
./.
====================
Either/DT
case/NN
fails/VBZ
to/TO
adhere/VB
to/TO
the/DT
Ethical/JJ
Guidelines/NNS
of/IN
the/DT
American/NN
Statistical/JJ
Association/NN
which/WDT
says/VBZ
``/CD
Avoid/JJ
the/DT
use/NN
of/IN
excessive/JJ
of/IN
inadequate/JJ
number/NN
of/IN
research/NN
subjects/NNS
by/IN
making/VBG
informed/VBN
recommendations/NNS
for/IN
study/NN
size/NN
''/NN
(/(
American/NNP
Statistical/JJ
Association/NN
,/,
1999/CD
)/)
./.
====================
While/IN
the/DT
exact/JJ
final/JJ
number/NN
that/IN
will/MD
be/VB
used/VBN
for/IN
the/DT
analysis/NN
will/MD
be/VB
unknown/JJ
due/JJ
to/TO
missing/VBG
information/NN
such/JJ
as/IN
lack/NN
of/IN
genotype/JJ
information/NN
and/CC
clinical/JJ
information/NN
,/,
it/PRP
is/VBZ
still/RB
desirable/JJ
to/TO
determine/VB
a/DT
target/NN
sample/NN
size/NN
based/VBN
on/IN
the/DT
proposed/JJ
study/NN
design/NN
./.
====================
The/DT
sample/JJ
size/NN
estimate/NN
will/MD
allow/VB
the/DT
estimation/NN
of/IN
total/JJ
cost/NN
of/IN
the/DT
proposed/JJ
study/NN
required/VBD
./.
====================
Typically/RB
,/,
the/DT
number/NN
of/IN
samples/NNS
is/VBZ
computed/VBN
to/TO
provide/VB
a/DT
fixed/JJ
level/NN
of/IN
power/JJR
under/IN
a/DT
specified/VBN
alternative/JJ
hypothesis/NN
./.
====================
The/DT
alternative/JJ
hypothesis/NN
usually/RB
represents/VBZ
a/DT
minimal/JJ
meaningful/JJ
difference/NN
in/IN
the/DT
frequency/NN
of/IN
genotypes/NNS
or/CC
alleles/NNS
between/IN
cases/NNS
and/CC
controls/VBZ
./.
====================
Power/JJR
(/(
1-/CD
probability/NN
of/IN
type/NN
II/CD
error/NN
)/)
is/VBZ
an/DT
important/JJ
consideration/NN
for/IN
several/JJ
reasons/NNS
./.
====================
Low/JJ
power/JJR
can/MD
cause/VB
a/DT
true/JJ
difference/NN
in/IN
allele/NN
frequencies/NNS
or/CC
genotype/NN
frequencies/NNS
between/IN
cases/NNS
and/CC
controls/VBZ
to/TO
be/VB
rejected/VBN
./.
====================
However/RB
,/,
too/RB
much/RB
power/JJR
may/MD
make/VB
results/NNS
statistically/RB
significant/JJ
that/DT
are/VBP
not/RB
meaningfully/RB
different/JJ
./.
====================
The/DT
probability/NN
of/IN
type/NN
I/CD
error/NN
(/(
a/DT
)/)
of/IN
0.05/CD
and/CC
power/JJR
of/IN
0.80/CD
and/CC
0.90/CD
has/VBZ
been/VBN
widely/RB
used/VBN
for/IN
the/DT
sample/NN
size/NN
estimation/NN
in/IN
genetic/JJ
association/NN
studies/NNS
./.
====================
In/IN
this/DT
paper/NN
,/,
we/PRP
restrict/VBP
our/PRP$
attention/NN
to/TO
the/DT
sample/JJ
size/NN
and/CC
power/JJR
calculations/NNS
for/IN
case-control/JJ
genetic/JJ
association/NN
studies/NNS
between/IN
a/DT
marker/NN
locus/NN
and/CC
a/DT
disease/NN
phenotype/NN
on/IN
a/DT
population-/NN
based/VBN
scale/NN
./.
====================
Either/DT
the/DT
candidate/NN
allelic/JJ
or/CC
genotypic/JJ
frequencies/NNS
are/VBP
compared/VBN
to/TO
evaluate/VB
genetic/JJ
associations/NNS
between/IN
cases/NNS
and/CC
controls/VBZ
./.
====================
The/DT
geneticist/NN
usually/RB
prefers/VBZ
====================
comparing/VBG
allelic/JJ
frequencies/NNS
on/IN
the/DT
grounds/NNS
that/DT
,/,
in/IN
the/DT
absence/NN
of/IN
an/DT
association/NN
,/,
sampling/JJ
genotypes/NNS
under/IN
Hardy-Weinberg/JJ
Equilibrium/NN
(/(
HWE/NN
)/)
is/VBZ
equivalent/JJ
to/TO
====================
sampling/VBG
gametes/NNS
,/,
or/CC
alleles/NNS
from/IN
the/DT
gene/NN
pool/NN
that/DT
gives/VBZ
rise/NN
to/TO
the/DT
population/NN
(/(
Lalouel/JJ
and/CC
Rohrwasser/NN
,/,
2002/CD
)/)
./.
====================
When/WRB
allele/NN
frequencies/NNS
are/VBP
compared/VBN
,/,
the/DT
two/CD
alleles/NNS
of/IN
each/DT
subject/JJ
are/VBP
treated/VBN
as/IN
independent/JJ
Even/RB
though/IN
comparison/NN
of/IN
allele/NN
frequencies/NNS
seems/VBZ
to/TO
be/VB
counter-intuitive/JJ
because/IN
alleles/NNS
sometimes/RB
do/VBP
not/RB
act/VB
independently/RB
,/,
this/DT
approach/NN
has/VBZ
been/VBN
often/RB
used/VBN
in/IN
genetic/JJ
association/NN
studies/NNS
(/(
e.g/FW
./.
====================
Apple/NN
et/FW
al./FW
,/,
1994/CD
;/:
Odunsi/NNP
et/FW
al./FW
,/,
1995/CD
)/)
./.
====================
Power/JJR
and/CC
sample/NN
size/NN
for/IN
chi-/NN
square/VBP
tests/NNS
for/IN
comparing/VBG
allelic/JJ
frequencies/NNS
can/MD
be/VB
found/VBN
in/IN
Lachin/NN
(/(
1977/CD
)/)
and/CC
Guenther/JJ
(/(
1973/CD
)/)
./.
====================
There/EX
are/VBP
many/JJ
available/JJ
statistical/JJ
software/NN
programs/NNS
that/DT
can/MD
be/VB
used/VBN
to/TO
estimate/VB
the/DT
sample/NN
size/NN
or/CC
power/JJR
needed/VBD
to/TO
detect/VB
minimal/JJ
allele/NN
frequencies/NNS
between/IN
cases/NNS
and/CC
controls/VBZ
./.
====================
For/IN
example/NN
,/,
commercial/JJ
software/RB
such/JJ
as/IN
nQuery/RB
(/(
Elashoff/NNP
,/,
2005/CD
)/)
or/CC
Power/JJR
and/CC
Precision/NN
(/(
Borenstein/NNP
et/FW
al./FW
,/,
2001/CD
)/)
or/CC
StatXact/JJ
(/(
Mehta/NNP
and/CC
Patel/NN
,/,
2006/CD
)/)
or/CC
non-commercial/JJ
software/RB
such/JJ
as/IN
PS/NN
(/(
Power/NNP
and/CC
Sample/JJ
size/NN
calculation/NN
,/,
which/WDT
is/VBZ
available/JJ
at/IN
http/NN
:/:
//biostat.mc.vanderbilt.edu/twiki/bin/view/Main/Pow/JJ
====================
erSampleSize/VBP
)/)
can/MD
be/VB
used/VBN
to/TO
estimate/VB
the/DT
sample/NN
size/NN
or/CC
power/JJR
based/VBN
on/IN
allele/NN
frequencies/NNS
of/IN
cases/NNS
and/CC
controls/VBZ
./.
====================
There/EX
are/VBP
two/CD
commonly/RB
used/VBN
statistical/JJ
tests/NNS
for/IN
the/DT
estimation/NN
of/IN
sample/JJ
size/NN
and/CC
power/JJR
using/VBG
genotypes/NNS
in/IN
genetic/JJ
association/NN
studies/NNS
./.
====================
One/CD
is/VBZ
the/DT
Cochran-/NN
Armitage/NN
linear/JJ
trend/NN
test/NN
(/(
Armitage/NN
,/,
1955/CD
)/)
and/CC
the/DT
other/JJ
is/VBZ
a/DT
genotypic/JJ
association/NN
test/NN
(/(
Gordon/NN
etal./FW
,/,
2002/CD
)/)
./.
====================
Sasieni/NNP
(/(
1997/CD
)/)
investigates/VBZ
the/DT
relationship/NN
between/IN
the/DT
approaches/NNS
of/IN
using/VBG
alleles/NNS
and/CC
genotypes/NNS
,/,
and/CC
con­/FW
cludes/NNS
that/DT
the/DT
allelic/JJ
chi-square/NN
test/NN
based/VBN
on/IN
alleles/NNS
is/VBZ
inappropriate/JJ
when/WRB
genotype/JJ
frequencies/NNS
violate/JJ
HWE/NN
and/CC
that/IN
the/DT
Cochran-Armitage/NN
's/POS
linear/JJ
trend/NN
test/NN
should/MD
be/VB
used/VBN
instead/RB
./.
====================
The/DT
two/CD
tests/NNS
are/VBP
asymptotically/RB
equiv­/JJ
alent/JJ
under/IN
HWE/NN
./.
====================
Kang/NN
et/FW
al./FW
,/,
(/(
2005/CD
)/)
investigate/VBP
per­/IN
formances/VBZ
of/IN
the/DT
allelic/JJ
chi-square/NN
test/NN
when/WRB
HWE/NN
is/VBZ
violated/VBN
./.
====================
They/PRP
investigate/VBP
the/DT
maximum/NN
and/CC
minimum/JJ
values/NNS
of/IN
type/NN
I/CD
error/NN
rate/NN
of/IN
the/DT
allelic/JJ
chi-square/NN
test/NN
by/IN
using/VBG
nonlinear/JJ
programming/VBG
and/CC
simulation/JJ
./.
====================
It/PRP
is/VBZ
re­/VBN
vealed/JJ
that/DT
,/,
under/IN
violated/JJ
HWE/NN
,/,
the/DT
allelic/JJ
chi-square/NN
test/NN
has/VBZ
distorted/VBN
type/NN
I/CD
error/NN
rate/NN
./.
====================
Allele/DT
frequencies/NNS
should/MD
be/VB
compared/VBN
only/RB
when/WRB
genotype/NN
frequencies/NNS
are/VBP
in/IN
HWE/NN
./.
====================
In/IN
a/DT
single/JJ
nucleotide/NN
polymorphism/NN
(/(
SNP/NN
)/)
with/IN
two/CD
possible/JJ
alleles/NNS
,/,
'/``
A/DT
'/``
or/CC
'/``
B/NN
'/``
,/,
there/EX
are/VBP
three/CD
possible/JJ
genotypes/NNS
,/,
'AA/NNP
’/CD
,/,
’/NNP
AB/LS
’/CD
,/,
and/CC
'BB*/NNP
./.
====================
Study/NN
subjects/NNS
can/MD
be/VB
====================
classified/VBN
into/IN
a/DT
2x3/NN
table/JJ
based/VBN
on/IN
each/DT
subject/JJ
’/CD
s/NNS
disease/NN
status/NN
(/(
case/NN
or/CC
control/NN
)/)
and/CC
genotype/NN
./.
====================
Table/JJ
1/CD
shows/VBZ
the/DT
genotype/NN
data/NNS
from/IN
case-control/JJ
studies/NNS
./.
====================
Here/RB
,/,
the/DT
two/CD
rows/NNS
refer/VBP
to/TO
disease/NN
status/NN
(/(
cases/NNS
and/CC
controls/VBZ
)/)
,/,
and/CC
the/DT
3/CD
columns/NNS
refer/VBP
to/TO
the/DT
genotypes/NNS
./.
====================
Given/IN
disease/NN
status/NN
,/,
the/DT
distribution/NN
of/IN
genotypes/NNS
is/VBZ
multinomial/JJ
with/IN
parameter/NN
vectors/NNS
p=/RB
(/(
po/NN
,/,
Pi/NNP
,/,
P2/NN
)/)
for/IN
cases/NNS
and/CC
q=/RB
(/(
qo/RB
,/,
qi/RB
,/,
q2/RB
)/)
for/IN
controls/NNS
,/,
where/WRB
the/DT
subscript/NN
corresponds/VBZ
to/TO
the/DT
number/NN
of/IN
high/JJ
risk/NN
alleles/NNS
in/IN
the/DT
genotype/NN
./.
====================
Slager/RBR
and/CC
Schaid/JJ
(/(
2001/CD
)/)
specify/VBP
the/DT
values/NNS
of/IN
Pi/NN
and/CC
qi/FW
using/VBG
the/DT
information/NN
on/IN
penetrances/NNS
(/(
fo/CD
,/,
fi/RB
,/,
f2/NN
)/)
and/CC
the/DT
marginal/JJ
genotype/NN
probabilities/NNS
(/(
go/NN
,/,
gi/NNP
,/,
g2/NN
)/)
./.
====================
Here/RB
,/,
the/DT
penetrance/NN
fj/JJ
is/VBZ
the/DT
conditional/JJ
probability/NN
P/NN
(/(
affected|/IN
j/RB
copies/NNS
of/IN
disease/NN
allele/NN
)/)
,/,
where/WRB
j=0,1/NN
,/,
or/CC
2/CD
for/IN
a/DT
di-allelic/JJ
disease/NN
locus/NN
./.
====================
The/DT
information/NN
on/IN
penetrance/NN
and/CC
the/DT
marginal/JJ
genotype/NN
probabilities/NNS
can/MD
be/VB
obtained/VBN
from/IN
the/DT
prior/JJ
data/NNS
based/VBN
on/IN
the/DT
literature/NN
or/CC
pilot/NN
study/NN
or/CC
an/DT
assumed/VBN
genetic/JJ
model/NN
./.
====================
The/DT
values/NNS
of/IN
p/NN
,/,
and/CC
qi/NN
can/MD
be/VB
calculated/VBN
from/IN
the/DT
following/VBG
equations/NNS
./.
====================
Once/RB
pi/NN
and/CC
q/RB
,/,
are/VBP
computed/VBN
from/IN
fi/CD
and/CC
gi/FW
,/,
sample/JJ
size/NN
software/JJ
for/IN
Cochran-Armitage/NN
trend/NN
test/NN
can/MD
be/VB
used/VBN
to/TO
estimate/VB
the/DT
sample/JJ
size/NN
or/CC
power/JJR
needed/VBD
for/IN
the/DT
association/NN
between/IN
genotypes/NNS
and/CC
disease/NN
status/NN
./.
====================
Slager/NN
and/CC
Schaid/NN
(/(
2001/CD
)/)
provide/VBP
a/DT
sample/JJ
size/NN
formula/NN
====================
for/IN
Cochran-Armitage/NN
trend/NN
test/NN
,/,
and/CC
evaluate/VBP
the/DT
performances/NNS
of/IN
their/PRP$
sample/JJ
size/NN
formula/FW
under/IN
different/JJ
disease/NN
prevalence/NN
,/,
genotypic/JJ
relative/JJ
risks/NNS
and/CC
allelic/JJ
effects/NNS
such/JJ
as/IN
multiplicative/JJ
,/,
additive/JJ
,/,
dominant/JJ
and/CC
recessive/JJ
models/NNS
based/VBN
on/IN
high-risk/JJ
allele/NN
frequencies/NNS
./.
====================
Cochran-Armitage/NN
trend/NN
test/NN
can/MD
be/VB
obtained/VBN
as/IN
the/DT
score/NN
test/NN
using/VBG
the/DT
logistic/JJ
regression/NN
with/IN
a/DT
single/JJ
covariate/VBP
depending/VBG
on/IN
the/DT
individual/JJ
’/NN
s/NNS
genotype/NN
./.
====================
Cochran-Armitage/NN
trend/NN
test/NN
is/VBZ
a/DT
locally/RB
optimal/JJ
test/NN
for/IN
the/DT
given/VBN
set/NN
of/IN
scores/NNS
./.
====================
Slager/RBR
and/CC
Schaid/JJ
(/(
2001/CD
)/)
demonstrate/VBP
that/IN
their/PRP$
sample/JJ
size/NN
formula/FW
is/VBZ
generally/RB
quite/RB
accurate/JJ
by/IN
showing/VBG
that/IN
their/PRP$
empirical/JJ
powers/NNS
are/VBP
close/JJ
to/TO
the/DT
expected/VBN
powers/NNS
through/IN
simulation/JJ
./.
====================
When/WRB
the/DT
variance/NN
of/IN
the/DT
Cochran-Armitage/NN
trend/NN
test/NN
statistic/JJ
is/VBZ
known/VBN
,/,
the/DT
formulas/NNS
for/IN
sample/JJ
size/NN
and/CC
power/JJR
are/VBP
readily/RB
obtained/VBN
./.
====================
In/IN
practice/NN
,/,
the/DT
variance/NN
of/IN
the/DT
test/NN
statistics/NNS
is/VBZ
unknown/JJ
,/,
and/CC
needs/VBZ
to/TO
be/VB
estimated/VBN
./.
====================
Freidlin/NN
et/FW
al/JJ
./.
====================
(/(
2002/CD
)/)
present/JJ
formulas/IN
for/IN
the/DT
sample/NN
size/NN
====================
needed/VBN
for/IN
case-control/JJ
genetic/JJ
association/NN
studies/NNS
pre-specified/VBD
power/JJR
when/WRB
the/DT
variance/NN
of/IN
the/DT
test/NN
statistic/JJ
is/VBZ
unknown/JJ
./.
====================
Since/IN
these/DT
values/NNS
are/VBP
typically/RB
unknown/JJ
for/IN
complex/NN
diseases/NNS
such/JJ
as/IN
diabetes/NNS
,/,
cancer/NN
,/,
and/CC
cardiovascular/JJ
disease/NN
,/,
one/CD
considers/VBZ
a/DT
range/NN
of/IN
values/NNS
for/IN
parameters/NNS
to/TO
deal/JJ
with/IN
such/JJ
uncertainty/NN
./.
====================
Cox/NN
and/CC
Hinkley/JJ
(/(
1974/CD
)/)
suggest/VBP
reporting/VBG
median/JJ
sample/NN
size/NN
and/or/CC
power/JJR
values/NNS
or/CC
worst-case/NN
scenarios/NNS
that/DT
yield/VBP
the/DT
largest/JJS
sample/NN
size/NN
needed/VBD
or/CC
the/DT
smallest/JJS
power/JJR
./.
====================
This/DT
suggestion/NN
has/VBZ
been/VBN
used/VBN
in/IN
several/JJ
genetic/JJ
applications/NNS
(/(
Cousin/NN
et/FW
al./FW
,/,
2003/CD
;/:
Gordon/NN
et/FW
al./FW
,/,
2005/CD
;/:
Zheng/NNP
and/CC
Tian/JJ
,/,
2005/CD
)/)
./.
====================
This/DT
suggestion/NN
leads/VBZ
us/PRP
to/TO
observe/VB
a/DT
distribution/NN
of/IN
sample/JJ
size/NN
(/(
or/CC
power/JJR
)/)
values/NNS
for/IN
the/DT
range/NN
of/IN
parameter/NN
values/NNS
considered/VBN
,/,
including/VBG
minimum/JJ
,/,
maximum/JJ
,/,
median/JJ
,/,
and/CC
average/NN
sample/NN
size/NN
(/(
or/CC
power/JJR
)/)
values/NNS
./.
====================
Association/NN
between/IN
disease/NN
status/NN
and/CC
genotype/NN
is/VBZ
tested/VBN
using/VBG
the/DT
chi-square/NN
test/NN
statistic/JJ
on/IN
2/CD
>/JJR
</JJR
3/CD
contingency/NN
tables/NNS
./.
====================
If/IN
the/DT
chi-square/NN
test/NN
yields/VBZ
a/DT
significant/JJ
result/NN
,/,
then/RB
we/PRP
may/MD
say/VB
that/DT
the/DT
marker/NN
locus/NN
seems/VBZ
to/TO
be/VB
in/IN
close/JJ
proximity/NN
to/TO
such/JJ
a/DT
susceptibility/NN
locus/NN
for/IN
a/DT
disease/NN
./.
====================
Sample/JJ
size/NN
or/CC
power/JJR
can/MD
be/VB
estimated/VBN
using/VBG
the/DT
noncentrality/NN
parameter/NN
,/,
which/WDT
can/MD
be/VB
computed/VBN
from/IN
the/DT
asymptotic/JJ
distribution/NN
of/IN
the/DT
chi-square/NN
test/NN
on/IN
2/CD
>/JJR
</JJR
3/CD
contingency/NN
tables/NNS
under/IN
a/DT
specified/VBN
alternative/JJ
hypothesis/NN
(/(
Mitra/NN
,/,
1958/CD
)/)
./.
====================
Sample/JJ
size/NN
estimate/NN
software/JJ
such/JJ
as/IN
nQuery/RB
can/MD
be/VB
used/VBN
to/TO
estimate/VB
the/DT
sample/NN
size/NN
or/CC
power/JJR
from/IN
2x3/NN
contingency/NN
tables/NNS
./.
====================
Purcell/NN
etal/JJ
./.
====================
(/(
2003/CD
)/)
give/VBP
description/NN
of/IN
Genetic/JJ
Power/NN
Calculator/NN
(/(
GPC/NN
)/)
package/NN
which/WDT
performs/VBZ
power/JJR
calculations/NNS
for/IN
the/DT
design/NN
of/IN
linkage/NN
and/CC
association/NN
genetic/JJ
mapping/NN
studies/NNS
of/IN
complex/NN
traits/VBZ
./.
====================
GPC/NN
software/JJ
can/MD
be/VB
obtained/VBN
from/IN
the/DT
website/JJ
http/NN
:/:
//pngu.mgh.harvard.edu/-purcell/gpc//JJ
./.
====================
There/EX
is/VBZ
considerable/JJ
mistyping/VBG
in/IN
most/JJS
genotype/JJ
data/NNS
due/IN
to/TO
biochemical/JJ
anomalies/NNS
,/,
human/JJ
oversights/NNS
,/,
or/CC
shortcomings/VBZ
in/IN
genotyping/VBG
scoring/VBG
software/JJ
(/(
Sobel/JJ
et/FW
al./FW
,/,
2002/CD
)/)
./.
====================
Genotyping/VBG
errors/NNS
lead/VBP
to/TO
inflation/NN
in/IN
type/NN
I/CD
errors/NNS
or/CC
a/DT
decrease/NN
in/IN
power/JJR
,/,
and/CC
bias/NNS
in/IN
statistical/JJ
inference/NN
in/IN
genetic/JJ
association/NN
studies/NNS
./.
====================
Gordon/NN
et/FW
al./FW
,/,
(/(
2001/CD
,/,
2002/CD
,/,
2003/CD
)/)
quantify/RB
the/DT
genotyping/VBG
error/NN
effects/NNS
on/IN
the/DT
sample/JJ
size/NN
and/CC
power/JJR
needed/VBD
to/TO
maintain/VB
asymptotic/JJ
type/NN
I/CD
error/NN
and/CC
type/NN
II/CD
error/NN
rates/NNS
for/IN
case-control/JJ
genetic/JJ
association/NN
studies/NNS
between/IN
a/DT
SNP/NN
locus/NN
and/CC
a/DT
disease/NN
phenotype/NN
./.
====================
Software/RB
PAWE/NN
(/(
Power/NN
for/IN
Association/NN
With/IN
Errors/NNS
)/)
to/TO
estimate/VB
the/DT
====================
sample/NN
size/NN
and/CC
power/JJR
for/IN
genetic/JJ
case-control/NN
association/NN
studies/NNS
allowing/VBG
for/IN
genotyping/VBG
error/NN
can/MD
be/VB
found/VBN
from/IN
http/NN
:/:
//linkage.rockefeller.edu/pawe//JJ
./.
====================
Software/DT
PAWE/NN
provides/VBZ
power/JJR
and/CC
sample/NN
size/NN
calculations/NNS
for/IN
case-control/JJ
studies/NNS
with/IN
a/DT
di-al/JJ
lei/NNS
ic/JJ
locus/NN
such/JJ
as/IN
SNP/NN
in/IN
the/DT
presence/NN
of/IN
genotyping/VBG
errors/NNS
./.
====================
The/DT
results/NNS
obtained/VBN
from/IN
data/NNS
without/IN
genotyping/VBG
errors/NNS
by/IN
software/JJ
PAWE/NN
are/VBP
identical/JJ
to/TO
those/DT
obtained/VBN
by/IN
other/JJ
genetic/JJ
association/NN
test/NN
power/JJR
calculators/NNS
,/,
for/IN
example/NN
,/,
the/DT
Genetic/JJ
Power/NN
Calculator/NN
(/(
GPC/NN
)/)
./.
====================
Software/DT
PAWE-3D/NN
(/(
Gordon/NN
et/FW
al./FW
,/,
2005/CD
)/)
plots/NNS
for/IN
power/JJR
and/CC
sample/JJ
size/NN
calculations/NNS
over/IN
a/DT
range/NN
of/IN
parameters/NNS
including/VBG
genotypic/JJ
errors/NNS
for/IN
the/DT
Cochran-Armitage/NN
linear/JJ
trend/NN
test/NN
and/CC
the/DT
genotypic/JJ
association/NN
test/NN
./.
====================
Software/RB
is/VBZ
available/JJ
from/IN
the/DT
website/JJ
http/NN
:/:
//linkage.rockefeller.edu/pawe3d//JJ
./.
====================
Kang/VBG
et/FW
al./FW
,/,
(/(
2004/CD
)/)
examine/VBP
which/WDT
genotype/NN
misclassification/NN
errors/NNS
are/VBP
most/RBS
costly/RB
,/,
in/IN
terms/NNS
of/IN
increased/VBN
sample/NN
size/NN
to/TO
maintain/VB
asymptotic/JJ
power/JJR
and/CC
significance/NN
level/NN
./.
====================
They/PRP
use/VBP
chi-square/NN
test/NN
for/IN
2x3/NN
contingency/NN
tables/NNS
instead/RB
of/IN
2x2/NN
contingency/NN
tables/NNS
since/IN
the/DT
allelic/JJ
chi-square/NN
test/NN
based/VBN
on/IN
alleles/NNS
is/VBZ
inappropriate/JJ
when/WRB
genotype/NN
frequencies/NNS
violate/VBP
HWE/NN
./.
====================
Use/NN
of/IN
allelic/JJ
test/NN
may/MD
be/VB
inappropriate/JJ
even/RB
in/IN
HWE/NN
when/WRB
genotyping/VBG
errors/NNS
are/VBP
present/JJ
./.
====================
They/PRP
show/VBP
that/IN
misclassifying/VBG
a/DT
more/RBR
common/JJ
genotype/NN
as/IN
the/DT
less/RBR
common/JJ
genotype/NN
requires/VBZ
a/DT
larger/JJR
sample/NN
size/NN
than/IN
the/DT
reverse/JJ
misclassification/NN
./.
====================
Edwards/NNS
et/FW
al/JJ
./.
====================
(/(
2005/CD
)/)
describe/VBP
high/JJ
phenotype/NN
mis­/NN
classification/NN
rates/NNS
cited/VBN
in/IN
several/JJ
studies/NNS
./.
====================
Edwards/NNS
et/FW
al/JJ
./.
====================
(/(
2005/CD
)/)
present/JJ
an/DT
impact/NN
of/IN
phenotype/NN
error/NN
,/,
also/RB
known/VBN
as/IN
diagnostic/JJ
error/NN
,/,
on/IN
power/JJR
and/CC
sample/JJ
size/NN
es­/NN
timates/NNS
for/IN
case-control/JJ
genetic/JJ
association/NN
studies/NNS
be­/IN
tween/CD
a/DT
disease/NN
phenotype/NN
and/CC
a/DT
marker/NN
locus/NN
./.
====================
The/DT
sensitivity/NN
and/CC
specificity/NN
of/IN
the/DT
diagnostic/JJ
test/NN
are/VBP
de­/VBN
fined/JJ
as/IN
sensitivity=Pr/JJ
(/(
observed/VBN
case/NN
|/CD
true/JJ
affected/VBN
)/)
and/CC
specificity=Pr/NN
(/(
observed/VBN
control/NN
|/CD
true/JJ
unaffected/JJ
)/)
./.
====================
Two/CD
types/NNS
of/IN
diagnostic/JJ
errors/NNS
are/VBP
:/:
Pr/JJ
(/(
observed/VBN
control/NN
|/CD
true/JJ
affected/VBN
)/)
=/JJ
1/CD
-/:
sensitivity/NN
and/CC
Pr/NN
(/(
observed/VBN
case/NN
|/CD
true/JJ
unaffected/JJ
)/)
=/JJ
1/CD
-/:
specificity/NN
./.
====================
An/DT
example/NN
of/IN
diagnostic/JJ
errors/NNS
involves/VBZ
the/DT
use/NN
of/IN
the/DT
prostate/NN
specific/JJ
antigen/NN
(/(
PSA/NN
)/)
test/NN
for/IN
diagnosis/NN
of/IN
prostate/NN
cancer/NN
./.
====================
Although/IN
prostate/NN
cancer/NN
is/VBZ
the/DT
second/JJ
leading/VBG
cause/VBP
of/IN
cancer/NN
deaths/NNS
in/IN
men/NNS
and/CC
accounted/VBN
for/IN
an/DT
estimated/VBN
220,900/CD
new/JJ
cases/NNS
and/CC
28,900/CD
deaths/NNS
in/IN
the/DT
United/JJ
States/NNS
in/IN
2003/CD
,/,
screening/VBG
for/IN
it/PRP
with/IN
the/DT
PSA/NN
blood/NN
test/NN
and/CC
digital/JJ
rectal/JJ
exam/RB
(/(
DRE/NN
)/)
remains/VBZ
controversial/JJ
./.
====================
Screening/VBG
can/MD
not/RB
predict/VB
the/DT
kind/NN
of/IN
cancer/NN
====================
a/DT
man/JJ
may/MD
have/VB
and/CC
who/WP
will/MD
die/VBP
from/IN
it/PRP
./.
====================
As/IN
a/DT
screening/NN
test/NN
,/,
PSA/NN
has/VBZ
a/DT
sensitivity/NN
of/IN
about/RB
67.5/CD
%/NN
to/TO
80/CD
%/NN
and/CC
a/DT
specificity/NN
of/IN
about/RB
60/CD
%/NN
to/TO
70/CD
%/NN
when/WRB
the/DT
level/NN
is/VBZ
greater/JJR
than/IN
4.0/CD
ng/ml_/NN
(/(
American/NNP
Urological/JJ
Association/NN
,/,
2000/CD
;/:
Catalona/NNP
et/FW
al./FW
,/,
1991/CD
;/:
Brawer/RBR
,/,
1999/CD
;/:
Oesterling/VBG
et/FW
al./FW
,/,
1993/CD
;/:
Carter/NN
et/FW
al./FW
,/,
1992/CD
)/)
./.
====================
Although/IN
autopsy/NN
studies/NNS
have/VBP
shown/VBN
that/IN
approximately/RB
one/CD
in/IN
three/CD
men/NNS
over/IN
age/NN
50/CD
has/VBZ
histological/JJ
evidence/NN
of/IN
prostate/NN
cancer/NN
,/,
most/JJS
have/VBP
clinically/RB
insignificant/JJ
disease/NN
and/CC
only/RB
about/RB
3/CD
%/NN
of/IN
men/NNS
will/MD
die/VBP
from/IN
it/PRP
(/(
American/NNP
Urological/JJ
Association/NN
,/,
2000/CD
)/)
./.
====================
Edwards/NNS
et/FW
al/JJ
./.
====================
(/(
2005/CD
)/)
conduct/NN
a/DT
genotypic/JJ
test/NN
of/IN
association/NN
using/VBG
the/DT
Pearson/NN
chi-square/NN
test/NN
statistic/JJ
on/IN
2x3/NN
contingency/NN
tables/NNS
in/IN
the/DT
presence/NN
of/IN
phenotype/NN
errors/NNS
./.
====================
Sample/JJ
size/NN
or/CC
power/JJR
is/VBZ
obtained/VBN
as/IN
a/DT
function/NN
of/IN
noncentrality/JJ
parameter/NN
expressed/VBN
in/IN
terms/NNS
of/IN
sample/JJ
sizes/NNS
,/,
genotype/NN
frequencies/NNS
,/,
and/CC
phenotype/NN
error/NN
model/NN
parameters/NNS
./.
====================
Zheng/VBG
and/CC
Tian/JJ
(/(
2005/CD
)/)
investigate/VBP
the/DT
impact/NN
of/IN
phenotype/NN
errors/NNS
on/IN
sample/NN
size/NN
and/CC
power/JJR
using/VBG
the/DT
Cochran-Armitage/NN
trend/NN
test/NN
under/IN
various/JJ
genetic/JJ
models/NNS
./.
====================
Both/DT
Edwards/NNS
et/FW
al/JJ
./.
====================
(/(
2005/CD
)/)
and/CC
Zheng/JJ
and/CC
Tian/JJ
(/(
2005/CD
)/)
make/VBP
a/DT
key/JJ
assumption/NN
that/DT
phenotype/NN
errors/NNS
are/VBP
random/JJ
and/CC
independent/JJ
,/,
and/CC
furthermore/RB
they/PRP
are/VBP
non-differential/JJ
with/IN
respect/NN
to/TO
a/DT
particular/JJ
genotype/NN
./.
====================
Both/DT
Zheng/JJ
and/CC
Tian/JJ
(/(
2005/CD
)/)
and/CC
Edwards/NNS
et/FW
al/JJ
./.
====================
(/(
2005/CD
)/)
illustrate/VBP
that/DT
phenotype/NN
misclassification/NN
errors/NNS
can/MD
substantially/RB
decrease/NN
the/DT
asymptotic/JJ
power/JJR
to/TO
detect/VB
association/NN
between/IN
a/DT
trait/JJ
locus/NN
and/CC
a/DT
marker/NN
locus/NN
./.
====================
Software/RB
PAWE-PH/NN
to/TO
estimate/VB
power/JJR
or/CC
sample/JJ
size/NN
under/IN
random/JJ
phenotype/NN
misclassification/NN
errors/NNS
or/CC
diagnostic/JJ
errors/NNS
is/VBZ
available/JJ
from/IN
the/DT
website/JJ
http/NN
:/:
//linkage/JJ
./.
====================
rockefeller.edu/pawe/paweph.htm/NN
./.
====================
One/CD
of/IN
interesting/JJ
findings/NNS
is/VBZ
that/IN
for/IN
many/JJ
diseases/NNS
in/IN
which/WDT
prevalence/VBP
is/VBZ
less/RBR
than/IN
or/CC
equal/JJ
to/TO
10/CD
%/NN
,/,
it/PRP
is/VBZ
much/RB
more/RBR
important/JJ
to/TO
insure/JJ
that/DT
cases/NNS
are/VBP
truly/RB
cases/NNS
rather/RB
than/IN
controls/NNS
being/VBG
truly/RB
controls/VBZ
(/(
Edwards/NNS
et/FW
al./FW
,/,
2CO5/CD
,/,
Zheng/NNP
and/CC
Tian/JJ
,/,
2005/CD
)/)
./.
====================
That/DT
is/VBZ
,/,
it/PRP
is/VBZ
much/RB
more/RBR
important/JJ
to/TO
have/VB
less/RBR
phenotype/NN
errors/NNS
in/IN
cases/NNS
than/IN
in/IN
controls/NNS
./.
====================
Ji/NN
et/FW
al/JJ
./.
====================
(/(
in/IN
press/NN
)/)
derive/VBP
the/DT
sample/NN
size/NN
and/CC
power/JJR
esti­/NN
====================
mates/VBZ
using/VBG
the/DT
noncentrality/NN
parameter/NN
for/IN
the/DT
Likelihood/NN
Ratio/NN
Test/JJS
Allowing/JJ
for/IN
Error/JJ
(/(
LRTae/NNP
)/)
in/IN
the/DT
presence/NN
of/IN
random/JJ
phenotype/NN
and/CC
genotype/NN
errors/NNS
./.
====================
They/PRP
justify/RB
the/DT
sample/JJ
size/NN
and/CC
power/JJR
through/IN
simu­/JJ
lations/NNS
using/VBG
various/JJ
combinations/NNS
of/IN
genotype/NN
frequen­/JJ
cies/NNS
,/,
phenotype/NN
and/CC
genotype/NN
misclassification/NN
proba­/JJ
bilities/VBZ
,/,
total/JJ
sample/NN
size/NN
,/,
and/CC
ratio/NN
of/IN
cases/NNS
to/TO
controls/NNS
./.
====================
Contour/NN
plots/NNS
can/MD
be/VB
generated/VBN
using/VBG
the/DT
software/JJ
avail­/JJ
able/JJ
at/IN
the/DT
website/JJ
http/NN
:/:
//linkage.rockefeller.edu/lrtae//JJ
====================
contour.html/NN
./.
====================
Afshar-Kharghan/IN
et/FW
al/JJ
./.
====================
(/(
2004/CD
)/)
investigate/VBP
the/DT
association/NN
between/IN
the/DT
risk/NN
of/IN
coronary/JJ
heart/NN
disease/NN
and/CC
the/DT
variable/JJ
number/NN
of/IN
tandem/JJ
repeat/NN
(/(
VNTR/NN
)/)
polymorphism/NN
of/IN
platelet/NN
glycoprotein/NN
lb/NN
a/DT
(/(
GP/NN
lb/NN
a/DT
)/)
./.
====================
It/PRP
is/VBZ
shown/VBN
that/IN
CC/NN
genotype/NN
is/VBZ
associated/VBN
with/IN
a/DT
lower/JJR
risk/NN
of/IN
CHD/NN
events/NNS
than/IN
the/DT
other/JJ
genotypes/NNS
in/IN
African-/JJ
Americans/NNS
./.
====================
Kang/NN
etal/JJ
./.
====================
(/(
2004/CD
)/)
show/VBP
that/IN
HWE/NN
holdswell/NN
for/IN
GP/NN
lb/NN
a/DT
VNTR/NN
from/IN
the/DT
data/NNS
of/IN
Afshar-Kharghan/JJ
etal/JJ
./.
====================
(/(
2004/CD
)/)
./.
====================
The/DT
B/NN
allele/NN
frequencies/NNS
of/IN
case/NN
and/CC
controls/VBZ
in/IN
African-Americans/NNS
are/VBP
0.287/CD
and/CC
0.146/CD
for/IN
cases/NNS
and/CC
controls/VBZ
,/,
respectively/RB
./.
====================
Suppose/DT
that/DT
we/PRP
wish/VBP
to/TO
estimate/VB
the/DT
sample/JJ
size/NN
needed/VBD
to/TO
obtain/VB
90/CD
%/NN
power/JJR
at/IN
a/DT
5/CD
%/NN
significance/NN
level/NN
with/IN
an/DT
equal/JJ
number/NN
of/IN
case/NN
and/CC
controls/VBZ
for/IN
the/DT
chi-square/NN
test/NN
on/IN
genotypes/NNS
./.
====================
The/DT
sample/JJ
size/NN
calculations/NNS
are/VBP
conducted/VBN
using/VBG
the/DT
software/JJ
PAWE/JJ
(/(
http/RB
:/:
//linkage.rockefeller.edu/pawe//JJ
)/)
as/IN
follows/VBZ
:/:
on/IN
the/DT
first/JJ
page/JJ
,/,
'Sample/JJ
size/NN
calculations/NNS
for/IN
a/DT
fixed/JJ
power/RB
'/``
,/,
'Genetic/JJ
model/NN
free/JJ
method/NN
'/``
,/,
'Douglas/RB
Skol/JJ
Boehnke/CC
’/RB
,/,
'Significance/RB
level=0.05/NN
'/``
;/:
on/IN
the/DT
second/JJ
page/NN
,/,
'Power/RBR
level/NN
between/IN
0/CD
and/CC
1=0.90/CD
'/``
,/,
'Ratio/NNP
of/IN
controls/NNS
to/TO
cases=1/JJ
'/``
,/,
'Hardy/NNP
Weinberg/NNP
Equilibrium/NN
for/IN
cases/NNS
and/CC
controls=yes/VBZ
'/``
,/,
'/``
y=0.02/RB
'/``
and/CC
'/``
r|=0.02/RB
'/``
;/:
on/IN
the/DT
third/JJ
page/NN
,/,
'case/NNP
1/LS
allele/NN
frequency=0.287/RB
'/``
and/CC
'control/JJ
1/LS
allele/NN
frequency=0.146/RB
'/``
./.
====================
Then/RB
,/,
the/DT
required/VBN
sample/JJ
size/NN
estimates/NNS
are/VBP
111/CD
cases/NNS
and/CC
111/CD
controls/NNS
when/WRB
no/DT
errors/NNS
are/VBP
present/JJ
(/(
When/WRB
no/DT
errors/NNS
are/VBP
present/JJ
,/,
error/CC
model/NN
parameters/NNS
are/VBP
not/RB
important/JJ
since/IN
we/PRP
only/RB
look/RB
at/IN
the/DT
sample/JJ
size/NN
estimates/NNS
from/IN
the/DT
results/NNS
of/IN
'Data/JJ
Without/IN
Error/NN
'/``
)/)
./.
====================
Let/NN
's/POS
assume/NN
that/DT
the/DT
probability/NN
of/IN
misclassifying/VBG
homozygote/NN
as/IN
heterozygote/JJ
is/VBZ
2/CD
%/NN
and/CC
the/DT
probability/NN
of/IN
misclassifying/VBG
heterozygote/NN
as/IN
homozygote/JJ
is/VBZ
2/CD
%/NN
./.
====================
It/PRP
is/VBZ
assumed/VBN
that/IN
homozygotes/NNS
are/VBP
not/RB
misclassified/VBN
as/IN
other/JJ
homozygotes/NNS
./.
====================
The/DT
minimal/JJ
sample/NN
sizes/NNS
required/VBN
are/VBP
117/CD
cases/NNS
and/CC
117/CD
controls/NNS
when/WRB
random/JJ
genotype/JJ
errors/NNS
are/VBP
present/JJ
./.
====================
Thus/RB
,/,
the/DT
presence/NN
of/IN
genotype/NN
errors/NNS
results/NNS
in/IN
a/DT
5.94/CD
%/NN
increase/VBP
in/IN
sample/JJ
size/NN
to/TO
maintain/VB
the/DT
same/JJ
statistical/JJ
power/JJR
./.
====================
In/IN
this/DT
paper/NN
,/,
we/PRP
limit/VBP
our/PRP$
attention/NN
to/TO
the/DT
sample/NN
size/NN
and/CC
power/JJR
calculations/NNS
for/IN
case-control/JJ
genetic/JJ
association/NN
studies/NNS
between/IN
a/DT
marker/NN
locus/NN
and/CC
a/DT
disease/NN
phenotype/NN
on/IN
a/DT
population-based/JJ
scale/NN
./.
====================
In/IN
addition/NN
to/TO
genetic/JJ
association/NN
studies/NNS
using/VBG
unrelated/JJ
individuals/NNS
on/IN
a/DT
population-based/JJ
scale/NN
,/,
there/EX
are/VBP
family-based/VBN
genetic/JJ
====================
association/NN
studies/NNS
,/,
which/WDT
sample/NN
families/NNS
through/IN
one/CD
or/CC
more/RBR
probands/NNS
./.
====================
Family-based/JJ
genetic/JJ
association/NN
studies/NNS
are/VBP
originally/RB
developed/VBN
to/TO
deal/JJ
with/IN
problems/NNS
of/IN
population/NN
stratification/NN
./.
====================
Sample/JJ
size/NN
or/CC
power/JJR
of/IN
the/DT
family-based/JJ
association/NN
studies/NNS
can/MD
be/VB
estimated/VBN
with/IN
the/DT
family-based/JJ
association/NN
test/NN
(/(
FBAT/NN
)/)
statistic/JJ
(/(
Laird/JJ
et/FW
al/JJ
./.
====================
(/(
2000/CD
)/)
)/)
for/IN
virtually/RB
any/DT
given/VBN
study/NN
design/NN
and/CC
ascertainment/JJ
conditions/NNS
with/IN
the/DT
interactive/JJ
software/JJ
package/NN
PBAT/NN
(/(
http/NN
:/:
//www.biostat.harvard/JJ
,/,
edu/~clange//RB
default.htm/NN
)/)
./.
====================
Complex/NN
diseases/NNS
such/JJ
as/IN
hypertension/NN
and/CC
their/PRP$
complications/NNS
are/VBP
the/DT
consequence/NN
of/IN
interactions/NNS
between/IN
many/JJ
genetic/JJ
and/CC
environmental/JJ
factors/NNS
./.
====================
In/IN
general/JJ
,/,
the/DT
genes/NNS
contributing/VBG
to/TO
risk/NN
of/IN
hypertension/NN
do/VBP
not/RB
have/VB
the/DT
same/JJ
effects/NNS
in/IN
different/JJ
environments/NNS
,/,
or/CC
in/IN
different/JJ
genetic/JJ
backgrounds/NNS
./.
====================
Genetic/JJ
effects/NNS
may/MD
involve/VB
gene-gene/NN
interactions/NNS
as/IN
well/RB
as/IN
gene-environment/JJ
interactions/NNS
./.
====================
The/DT
software/JJ
Quanto/IN
(/(
http/NN
:/:
//hydra.usc.edu//JJ
gxe//JJ
)/)
computes/VBZ
sample/JJ
size/NN
or/CC
power/JJR
for/IN
association/NN
studies/NNS
of/IN
genes/NNS
,/,
gene-environment/JJ
interaction/NN
,/,
or/CC
gene-gene/JJ
interaction/NN
for/IN
a/DT
variety/NN
of/IN
study/NN
designs/VBZ
such/JJ
as/IN
matched/VBN
case-control/JJ
,/,
case-sibling/VBG
,/,
case-parent/JJ
,/,
and/CC
case-only/RB
designs/VBZ
./.
====================
In/IN
addition/NN
to/TO
case-control/JJ
association/NN
designs/VBZ
,/,
cohort/VBP
designs/NNS
are/VBP
also/RB
commonly/RB
used/VBN
to/TO
test/VB
genetic/JJ
association/NN
between/IN
a/DT
disease/NN
phenotype/NN
and/CC
a/DT
marker/NN
locus/NN
when/WRB
the/DT
sample/JJ
unit/NN
consists/VBZ
of/IN
unrelated/JJ
individuals/NNS
./.
====================
Some/DT
studies/NNS
such/JJ
as/IN
LUMINA/JJ
study/NN
(/(
Reveille/NN
et/FW
al./FW
,/,
1988/CD
)/)
and/CC
GENISOS/NN
study/NN
(/(
Reveille/NN
et/FW
al./FW
,/,
2001/CD
)/)
have/VBP
begun/VBN
to/TO
employ/VB
cohort/NN
designs/NNS
to/TO
study/VB
genetic/JJ
associations/NNS
using/VBG
unrelated/JJ
individuals/NNS
./.
====================
The/DT
advantages/NNS
of/IN
cohort/JJ
studies/NNS
over/IN
case-control/JJ
studies/NNS
are/VBP
ascertainment/JJ
of/IN
cases/NNS
,/,
elimination/NN
of/IN
recall/JJ
bias/NNS
,/,
and/CC
reduction/NN
of/IN
possible/JJ
population/NN
stratification/NN
./.
====================
The/DT
disadvantages/NNS
are/VBP
cost/JJ
and/CC
time/NN
needed/VBN
to/TO
recruit/VB
and/CC
measure/VB
genetic/JJ
and/CC
environmental/JJ
data/NNS
overtime/VBP
./.
====================
When/WRB
the/DT
outcome/NN
(/(
phenotype/NN
)/)
measurements/NNS
are/VBP
made/VBN
overtime/IN
in/IN
cohort/JJ
studies/NNS
,/,
sample/JJ
size/NN
for/IN
testing/VBG
genetic/JJ
association/NN
can/MD
be/VB
estimated/VBN
using/VBG
generalized/VBN
estimating/VBG
equation/NN
(/(
GEE/NN
)/)
approaches/NNS
for/IN
continuous/JJ
and/CC
binary/NN
outcomes/NNS
./.
====================
(/(
Jung/NN
and/CC
Ahn/NN
,/,
2003/CD
,/,
2005/CD
;/:
Ahn/NN
and/CC
Jung/NN
,/,
2003/CD
,/,
2005/CD
)/)
./.
====================
Jung/NN
and/CC
Ahn/NN
(/(
2003/CD
,/,
2005/CD
)/)
provide/VBP
a/DT
closed-form/JJ
sample/NN
size/NN
formula/FW
by/IN
accounting/VBG
for/IN
the/DT
missing/JJ
data/NNS
and/CC
the/DT
correlation/NN
between/IN
repeated/VBN
measurements/NNS
./.
====================
